A Kaplan–Meier analysis of data from 81 patients with HNSCC from a publicly available dataset (Oncomine) showed that patients with higher DDB2 expression had longer survival than those with lower DDB2 expression, which was significant at an alpha level of 0.05 (log-rank P = 0.0404) [71]. The gene discussed is DDB2; the disease is head and neck squamous cell carcinoma.